China Shineway Pharmaceutical Group Limited (HKG:2877)
8.48
+0.36 (4.44%)
Nov 20, 2026, 4:08 PM HKT
HKG:2877 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:2877 stock has a consensus rating of "Buy" and an average price target of $9.32. The average 1-year stock price forecast is 10.02% higher than the current stock price, while the lowest is $8.59 (+1.30%) and the highest is $10.06 (+18.70%).
Price Target: $9.32 (+10.02%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:2877 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Mar '26 | Aug '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $10.04 | Buy | Maintains | $10.04 | +18.47% | Nov 14, 2026 |
Financial Forecast
Revenue This Year
2.34B
from 3.14B
Decreased by -25.24%
Revenue Next Year
2.35B
from 2.34B
Increased by 0.13%
EPS This Year
1.00
from 1.26
Decreased by -20.63%
EPS Next Year
1.07
from 1.00
Increased by 7.40%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.